Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: A novel system for screening potential inhibitors of HBV replication

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1715-1720

  Ladner, Stephanie K ^a   Otto, Michael J ^a   Barker, Christopher S ^a,b   Zaifert, Katie ^a   Wang, Guang Hua ^c   Guo, J U Tao ^c   Seeger, Christoph ^c   King, Robert W ^a  

^a Avid Therapeutics Inc   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1,9 DIHYDRO 9 [3BETA HYDROXY 4ALPHA (HYDROXYMETHYL)CYCLOPENTYL] 6H PURINE 6 ONE; ALPHA INTERFERON; ANTIVIRUS AGENT; EMTRICITABINE; LAMIVUDINE; POLYADENYLATED RNA; TETRACYCLINE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA; ZALCITABINE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA SYNTHESIS; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0030842540     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1715     Document Type: Article

References (34)

1. Acs, G., M. A. Sells, R. H. Purcell, P. Price, R. Engle, M. Shapiro, and M. Popper. 1987. Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc. Natl. Acad. Sci. USA 84:4641-4644.
2. Beasley, R. P., and L. Y. Hwang. 1984. Epidemiology of hepatocellular carcinoma, p. 209-224. In G. N. Vynas, J. L. Deinstag, and J. H. Hoofnagle (ed.), Viral hepatitis and liver disease. Grune & Stratton, New York, N.Y.
3. Christman, J. K., M. Gerber, P. M. Price, C. Flordellis, J. Edelman, and G. Acs. 1982. Amplification of expression of hepatitis B surface antigen in 3T3 cells co-transfected with a dominant-acting gene and cloned viral DNA. Proc. Natl. Acad. Sci. USA 79:1815-1819.
4. Cullen, B. R. 1986. Transactivation of human immunodeficiency virus occurs via a biomodal mechanism. Cell 46:973-982.
5. Davis, M. G., and R. W. Jansen. 1994. Inhibition of hepatitis B virus in tissue culture by alpha interferon. Antimicrob. Agents Chemother. 38:2921-2924.
6. Deinstag, J. I., R. P. Perrillo, E. R. Schiff, M. Bartholomew, C. Vicary, and M. Rubin. 1995. A preliminary trial of lamivudine for chronic hepatitis B infection. N. Engl. J. Med. 333:1657-1661.
7. Fallows, D. A., and S. P. Goff. 1995. Mutations in the ε sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcription. J. Virol. 69:3067-3073.
8. Fattovich, G., L. Brollo, A. Alberti, P. Pontisso, G. Giustina, and G. Realdi. 1988. Long-term follow-up of anti-HBe positive chronic active hepatitis B. Hepatology 8:1651-1654.
9. Furman, P. A., J. E. Wilson, J. E. Reardon, and G. R. Painter. 1995. The effect of absolute configuration on the anti-HIV and anti-HBV activity of nucleoside analogues. Antiviral Chem. Chemother. 6:345-355.
10. Ganem, D., and H. E. Varmus. 1987. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:651-693.
11. Gish, R. G., J. Y. N. Lau, L. Brooks, J. W. S. Fang, S. L. Steady, J. C. Imperial, R. Garcia-Kennedy, C. O. Esquivel, and E. B. Keeffe. 1996. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 23:1-7.
12. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
13. Honkoop, P., R. A. de Man, R. A. Heijtink, and S. W. Schalm. 1995. Hepatitis B reactivation after lamivudine. Lancet 346:1156-1157.
14. Knowles, B. B., C. C. Howe, and D. P. Aden. 1980. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209:497-499.
15. Korba, B. E., and G. Milman. 1991. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res. 15:217-228.
16. Korba, B. E., and J. L. Gerin. 1992. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antiviral Res. 19:55-70.
17. Korba, B. E., and M. R. Boyd. 1996. Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells. Antimicrob. Agents Chemother. 40:1282-1284.
18. Lau, J. Y. N., and T. L. Wright. 1993. Molecular virology and pathogenesis of hepatitis B. Lancet 342:1335-1340.
19. Lin, T.-S., M.-Z. Luo, M.-C. Liu, S. B. Pai, G. E. Dutschman, and Y.-C. Cheng. 1994. Synthesis and biological evaluation of 2′,3′-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). J. Med. Chem. 37:798-803.
20. Nair, V., and T. S. Jahnke. 1995. Antiviral activities of isomeric dideoxynucleosidcs of D-and L-related stereochemistry. Antimicrob. Agents Chemother. 39:1017-1029.
21. Popper, H., D. A. Shafritz, and J. H. Hoofnagle. 1987. Relations of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 7:764-772.
22. Price, P. M., R. Banerjee, and G. Acs. 1989. Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2′-deoxyguanosine. Proc. Natl. Acad. Sci. USA 86:8541-8544.
23. Scaglioni, P. P., M. Melegari, and J. R. Wands. 1997. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J. Virol. 71:345-353.
24. Schinazi, R. F., G. Gosselin, A. Faraj, B. E. Korba, D. C. Liotta, C. K. Chu, C. Mathé, J.-L. Imbach, and J.-P. Sommadossi. 1994. Pure nucleoside enantiomers of β-2′,3′-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro. Antimicrob. Agents Chemother. 38:2172-2174.
25. Sells, M. A., M.-L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84:1005-1009.
26. Sells, M. A., A. Z. Zelent, M. Shvartsman, and G. Acs. 1988. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62:2836-2844.
27. Shih, C., L.-S. Li, S. Roychoudhury, and M.-H. Ho. 1989. In vitro propagation of human hepatitis B virus in a rat hepatoma cell line. Proc. Natl. Acad. Sci. USA 86:6323-6327.
28. Summers, J., P. M. Smith, and A. L. Horwich. 1990. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 64:2819-2824.
29. Sureau, C., J. Romet-Lemonne, J. I. Mullins, and M. Essex. 1987. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47:37-47.
30. Sureau, C., J. W. Eichberg, G. B. Hubbard, J. L. Romet-Lemonne, and M. Essex. 1988. A molecularly cloned hepatitis B virus produced in vitro is infectious in a chimpanzee. J. Virol. 62:3064-3067.
31. Tagieva, N. E., R. Z. Gizatullin, V. M. Zakharyev, and L. L. Kisselev. 1995. A genome-integrated hepatitis B virus DNA in human neuroblastoma. Gene 152:277-278.
32. Thomas, H. C. 1988. Treatment of hepatitis B viral infection, p. 817-822. In A. J. Zuckerman (ed.), Viral hepatitis and liver disease. Alan R. Liss, Inc., New York, N.Y.
33. Tsurimoto, T., A. Fujiyama, and K. Matsubara. 1987. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoblastoma cell line transfectcd with the cloned viral DNA. Proc. Natl. Acad. Sci. USA 84:444-448.
34. Weiss, L., A. S. Kekule, U. Jakubowski, E. Burgelt, and P. H. Hofschneider. 1996. The HBV-producing cell line Hep G2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs. Virology 216:214-218.